Triamcinolone acetonide and Hair loss - a phase IV clinical study of FDA data
Summary:
Hair loss is found among people who take Triamcinolone acetonide, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Triamcinolone acetonide and have Hair loss. It is created by eHealthMe based on reports of 13,203 people who have side effects when taking Triamcinolone acetonide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
13,203 people reported to have side effects when taking Triamcinolone acetonide.
Among them, 237 people (1.8%) have Hair loss.
What is Triamcinolone acetonide?
Triamcinolone acetonide has active ingredients of triamcinolone acetonide. It is often used in eczema. eHealthMe is studying from 13,327 Triamcinolone acetonide users for its effectiveness, alternative drugs and more.
What is Hair loss?
Hair loss is found to be associated with 3,944 drugs and 3,384 conditions by eHealthMe.
Number of Triamcinolone acetonide and Hair loss reports submitted per year:
Time on Triamcinolone acetonide when people have Hair loss *:
Gender of people who have Hair loss when taking Triamcinolone acetonide*:
Age of people who have Hair loss when taking Triamcinolone acetonide *:
Common drugs people take besides Triamcinolone acetonide *:
Common side effects people have besides Hair loss *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Triamcinolone acetonide and have Hair loss?
Check whether Hair loss is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
Related studies
How severe was Hair loss and when was it recovered:
Expand to all the drugs that have ingredients of triamcinolone acetonide:
Alternative drugs to, pros and cons of Triamcinolone acetonide:
- Triamcinolone acetonide (13,327 reports)
Common Triamcinolone acetonide side effects:
- Drug ineffective: 1,988 reports
- Rashes (redness): 979 reports
- Itching: 803 reports
- Pain: 788 reports
- Fatigue (feeling of tiredness): 755 reports
- Macular degeneration (painless eye condition that leads to the gradual loss of central vision): 672 reports
- Dizziness: 603 reports
- Nausea and vomiting: 547 reports
- Joint pain: 543 reports
Browse all side effects of Triamcinolone acetonide:
a b c d e f g h i j k l m n o p q r s t u v w x y zHair loss treatments and more:
- Hair loss (238,842 reports)
COVID vaccines that are related to Hair loss:
- Hair loss in Moderna COVID Vaccine
- Hair loss in Pfizer BioNTech Covid Vaccine
- Hair loss in Johnson and Johnson Covid Vaccine
Common drugs associated with Hair loss:
- Taxotere: 34,064 reports
- Docetaxel: 25,062 reports
- Methotrexate: 16,710 reports
- Humira: 14,833 reports
- Enbrel: 14,300 reports
- Prednisone: 13,908 reports
- Neosar: 11,976 reports
- Remicade: 10,226 reports
- Orencia: 9,671 reports
- Arava: 8,730 reports
All the drugs that are associated with Hair loss:
- Hair loss (3,944 drugs)
Common conditions associated with Hair loss:
- Rheumatoid arthritis: 18,564 reports
- Multiple sclerosis: 13,366 reports
- Breast cancer: 11,002 reports
- Chemotherapy: 8,910 reports
- High blood pressure: 5,484 reports
All the conditions that are associated with Hair loss:
- Hair loss (3,384 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on triamcinolone acetonide (the active ingredients of Triamcinolone acetonide) and Triamcinolone acetonide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Celebrex and Hypolipidaemia - now
- Losartan Potassium and Ibrutinib drug interaction - 2 seconds ago
- Cetirizine Hydrochloride and Patella Fracture - 3 seconds ago
- Byetta and Dry Throat - 5 seconds ago
- Chlorzoxazone and Pancreatitis - 5 seconds ago
- Premarin and Latanoprost drug interaction - 6 seconds ago
- Ampyra and Heavy Or Prolong Menstrual Bleeding - 9 seconds ago
- Zithromax and Lopressor drug interaction - 9 seconds ago
- Methocarbamol and Lung Carcinoma Cell Type Unspecified Recurrent - 15 seconds ago
- Azathioprine and Obliterative Bronchiolitis - 17 seconds ago